Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sarah K. Popp"'
Autor:
Alessandra Petrelli, Sarah K. Popp, Riho Fukuda, Christopher R. Parish, Emanuele Bosi, Charmaine J. Simeonovic
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Type 1 diabetes (T1D) is an autoimmune disease resulting from the destruction of insulin-producing beta cells in pancreatic islets. T lymphocytes are the claimed pathogenic effectors but abnormalities of other immune cell types, including neutrophils
Externí odkaz:
https://doaj.org/article/f46e320346904984b6f30e047317c466
Autor:
Sarah K. Popp, Federica Vecchio, Debra J. Brown, Riho Fukuda, Yuri Suzuki, Yuma Takeda, Rikako Wakamatsu, Mahalakshmi A. Sarma, Jessica Garrett, Anna Giovenzana, Emanuele Bosi, Antony R.A. Lafferty, Karen J. Brown, Elizabeth E. Gardiner, Lucy A. Coupland, Helen E. Thomas, Beng H. Chong, Christopher R. Parish, Manuela Battaglia, Alessandra Petrelli, Charmaine J. Simeonovic
Publikováno v:
JCI Insight, Vol 7, Iss 2 (2022)
Platelet-neutrophil aggregates (PNAs) facilitate neutrophil activation and migration and could underpin the recruitment of neutrophils to the pancreas during type 1 diabetes (T1D) pathogenesis. PNAs, measured by flow cytometry, were significantly ele
Externí odkaz:
https://doaj.org/article/6ed7806b9e764fde908116c406bf2ddb
Autor:
Sarita Dhounchak, Sarah K Popp, Debra J Brown, D Ross Laybutt, Trevor J Biden, Stefan R Bornstein, Christopher R Parish, Charmaine J Simeonovic
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252607 (2021)
Heparan sulfate proteoglycans (HSPGs) consist of a core protein with side chains of the glycosaminoglycan heparan sulfate (HS). We have previously identified (i) the HSPGs syndecan-1 (SDC1), and collagen type XVIII (COL18) inside mouse and human isle
Externí odkaz:
https://doaj.org/article/68eb3c59062444408e639f2ff92b388d
Autor:
Charmaine J Simeonovic, Sarah K Popp, Lora M Starrs, Debra J Brown, Andrew F Ziolkowski, Barbara Ludwig, Stefan R Bornstein, J Dennis Wilson, Alberto Pugliese, Thomas W H Kay, Helen E Thomas, Thomas Loudovaris, Fui Jiun Choong, Craig Freeman, Christopher R Parish
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0191360 (2018)
Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells in pancreatic islets are progressively destroyed. Clinical trials of immunotherapies in recently diagnosed T1D patients have only transiently and partially impacted
Externí odkaz:
https://doaj.org/article/3bfbd0d7d48b4557a8441d019c004f28
Autor:
Sarah K. Popp, Christopher R. Parish, Charmaine J. Simeonovic, Trevor J. Biden, Sarita Dhounchak, D. Ross Laybutt, Debra J. Brown, Stefan R. Bornstein
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252607 (2021)
PLoS ONE, Vol 16, Iss 6, p e0252607 (2021)
Heparan sulfate proteoglycans (HSPGs) consist of a core protein with side chains of the glycosaminoglycan heparan sulfate (HS). We have previously identified (i) the HSPGs syndecan-1 (SDC1), and collagen type XVIII (COL18) inside mouse and human isle
Autor:
Charmaine J, Simeonovic, Sarah K, Popp, Debra J, Brown, Fei-Ju, Li, Antony R A, Lafferty, Craig, Freeman, Christopher R, Parish
Publikováno v:
Advances in experimental medicine and biology. 1221
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta cells in pancreatic islets. The degradation of the glycosaminoglycan heparan sulfate (HS) by the endo-β-D-glycosidase heparanase plays a critical role in multiple st
Autor:
Fei-Ju Li, Antony R Lafferty, Debra J. Brown, Christopher R. Parish, Sarah K. Popp, Craig Freeman, Charmaine J. Simeonovic
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030345204
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta cells in pancreatic islets. The degradation of the glycosaminoglycan heparan sulfate (HS) by the endo-β-D-glycosidase heparanase plays a critical role in multiple st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20b27eb3f944ed6eead155feda61973a
https://doi.org/10.1007/978-3-030-34521-1_24
https://doi.org/10.1007/978-3-030-34521-1_24
Autor:
Christopher R. Parish, Bornstein, Ziolkowski Af, Ludwig B, Kay Twh, Loudovaris T, Choong Fj, Pugliese A, Debra J. Brown, J. D. Wilson, Freeman C, Sarah K. Popp, Thomas He, Simeonovic Cj, Starrs Lm
Publikováno v:
Yearbook of Paediatric Endocrinology.
Autor:
Christopher R. Parish, J. Dennis Wilson, Helen E. Thomas, Fui Jiun Choong, Barbara Ludwig, Andrew F. Ziolkowski, Charmaine J. Simeonovic, Sarah K. Popp, Stefan R. Bornstein, Thomas W.H. Kay, Lora Starrs, Craig Freeman, Thomas Loudovaris, Debra J. Brown, Alberto Pugliese
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0191360 (2018)
PLoS ONE
PLoS ONE
Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells in pancreatic islets are progressively destroyed. Clinical trials of immunotherapies in recently diagnosed T1D patients have only transiently and partially impacted
Autor:
Andrew F. Ziolkowski, Sarah K. Popp, Craig Freeman, Charmaine J. Simeonovic, Christopher R. Parish
Publikováno v:
Journal of Clinical Investigation. 122:132-141
The autoimmune type 1 diabetes (T1D) that arises spontaneously in NOD mice is considered to be a model of T1D in humans. It is characterized by the invasion of pancreatic islets by mononuclear cells (MNCs), which ultimately leads to destruction of in